Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Waters

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
European Journal of Pain (London, England)|February 24, 2017
The development and assessment of the Worry About Pain QuestionnaireJ C Lefebvre, M P Jensen, S J Waters, et al.
Cancer Chemotherapy and Pharmacology|January 5, 2002
Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic miceH S Friedman, S T Keir, P J Houghton, et al.
Journal of Pediatric Hematology/Oncology|August 26, 2000
MGI 114: augmentation of antitumor activity when combined with topotecanS Weitman, H Barrera, R Moore, et al.
The Journal of Organic Chemistry|September 1, 2001
Structure-activity studies of antitumor agent irofulven (hydroxymethylacylfulvene) and analoguesT C McMorris, J Yu, R Lira, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
European Journal of Pain (London, England)|February 24, 2017
The development and assessment of the Worry About Pain QuestionnaireJ C Lefebvre, M P Jensen, S J Waters, et al.
Cancer Chemotherapy and Pharmacology|January 5, 2002
Activity of irofulven (6-hydroxymethylacylfulvene) in the treatment of glioblastoma multiforme-derived xenografts in athymic miceH S Friedman, S T Keir, P J Houghton, et al.
Journal of Pediatric Hematology/Oncology|August 26, 2000
MGI 114: augmentation of antitumor activity when combined with topotecanS Weitman, H Barrera, R Moore, et al.
The Journal of Organic Chemistry|September 1, 2001
Structure-activity studies of antitumor agent irofulven (hydroxymethylacylfulvene) and analoguesT C McMorris, J Yu, R Lira, et al.
Pageof 3